299 related articles for article (PubMed ID: 29579233)
1. Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy.
Turner E; Jones M; Vaz LR; Coleman T
Nicotine Tob Res; 2019 Jul; 21(8):1001-1010. PubMed ID: 29579233
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological interventions for promoting smoking cessation during pregnancy.
Coleman T; Chamberlain C; Davey MA; Cooper SE; Leonardi-Bee J
Cochrane Database Syst Rev; 2015 Dec; (12):CD010078. PubMed ID: 26690977
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological interventions for promoting smoking cessation during pregnancy.
Claire R; Chamberlain C; Davey MA; Cooper SE; Berlin I; Leonardi-Bee J; Coleman T
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD010078. PubMed ID: 32129504
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia.
Havard A; Choi SKY; Pearson SA; Chow CK; Tran DT; Filion KB
JAMA Netw Open; 2021 Nov; 4(11):e2136372. PubMed ID: 34842922
[TBL] [Abstract][Full Text] [Related]
5. Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials.
Nagano T; Katsurada M; Yasuda Y; Kobayashi K; Nishimura Y
Ther Adv Respir Dis; 2019; 13():1753466619875925. PubMed ID: 31533544
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials.
Zhong Z; Zhao S; Zhao Y; Xia S
Compr Psychiatry; 2019 Nov; 95():152125. PubMed ID: 31669972
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.
Siskind DJ; Wu BT; Wong TT; Firth J; Kisely S
Lancet Psychiatry; 2020 Sep; 7(9):762-774. PubMed ID: 32828166
[TBL] [Abstract][Full Text] [Related]
8. Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis.
Peckham E; Brabyn S; Cook L; Tew G; Gilbody S
BMC Psychiatry; 2017 Jul; 17(1):252. PubMed ID: 28705244
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.
Nollen NL; Ahluwalia JS; Sanderson Cox L; Okuyemi K; Lawrence D; Samuels L; Benowitz NL
JAMA Netw Open; 2021 Jan; 4(1):e2032053. PubMed ID: 33464316
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for promoting smoking cessation during pregnancy.
Coleman T; Chamberlain C; Davey MA; Cooper SE; Leonardi-Bee J
Cochrane Database Syst Rev; 2012 Sep; (9):CD010078. PubMed ID: 22972148
[TBL] [Abstract][Full Text] [Related]
11. Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials.
Rosen LJ; Galili T; Kott J; Goodman M; Freedman LS
Addiction; 2018 May; 113(5):805-816. PubMed ID: 29377409
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials.
Suissa K; Larivière J; Eisenberg MJ; Eberg M; Gore GC; Grad R; Joseph L; Reynier PM; Filion KB
Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28093398
[TBL] [Abstract][Full Text] [Related]
13. Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation.
Jackson SE; McGowan JA; Ubhi HK; Proudfoot H; Shahab L; Brown J; West R
Addiction; 2019 May; 114(5):787-797. PubMed ID: 30614586
[TBL] [Abstract][Full Text] [Related]
14. [Smoking cessation: Pharmacological strategies different from standard treatments].
Underner M; Perriot J; Peiffer G; Harika-Germaneau G; Jaafari N
Rev Pneumol Clin; 2018 Sep; 74(4):205-214. PubMed ID: 29773262
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.
Roberts E; Eden Evins A; McNeill A; Robson D
Addiction; 2016 Apr; 111(4):599-612. PubMed ID: 26594837
[TBL] [Abstract][Full Text] [Related]
16. Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study.
Tran DT; Preen DB; Einarsdottir K; Kemp-Casey A; Randall D; Jorm LR; Choi SKY; Havard A
BMC Med; 2020 Feb; 18(1):15. PubMed ID: 32019533
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of pharmacological intervention for smoking cessation in smokers with diseases: A systematic review and network meta-analysis.
Xing X; Shang X; Deng X; Guo K; Fenfen E; Zhou L; Wang Y; Yang C; Yang K; Li X
J Evid Based Med; 2023 Dec; 16(4):520-533. PubMed ID: 38102895
[TBL] [Abstract][Full Text] [Related]
18. Pharmacovigilance Assessment of Cardiac Implications of Nicotine Replacement Therapy Among Smokers.
Olawuyi O; Mathieson K
Curr Drug Saf; 2020; 15(3):173-180. PubMed ID: 32525783
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.
Mills EJ; Thorlund K; Eapen S; Wu P; Prochaska JJ
Circulation; 2014 Jan; 129(1):28-41. PubMed ID: 24323793
[TBL] [Abstract][Full Text] [Related]
20. Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis.
Smith PH; Weinberger AH; Zhang J; Emme E; Mazure CM; McKee SA
Nicotine Tob Res; 2017 Mar; 19(3):273-281. PubMed ID: 27613893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
